.png)
Breast Cancer Testing Market by Type - Global Industry Analysis & Forecast to 2027
Published On : October 2020 Pages : 147 Category: Pharma & Healthcare Report Code : HC1113404
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Breast Cancer Testing Market By Type (Imaging, Biopsy, Genomic Tests, Blood Tests)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Breast Cancer Testing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Breast Cancer Testing involves specialized medical care that focuses on providing relief from pain and other symptoms of a serious illness. These tests are done while undergoing other aggressive treatments, such as surgery, chemotherapy or radiation therapy.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Breast Cancer Testing Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Genomic Health
- Myriad Genetics, Inc.
- NanoString Technologies, Inc.
- Hologic Inc.
- Koninklijke Philips N.V.
- Danaher
- Becton
- Dickinson and Company
- C.R. Bard, Inc.
- Devicor Medical Products Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Breast Cancer Testing Market , ByType, Estimates and Forecast, 2017-2027 ($Million)
o Imaging
o Biopsy
o Genomic Tests
o Blood Tests
· Breast Cancer Testing Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Genomic Health
o Myriad Genetics, Inc.
o NanoString Technologies, Inc.
o Hologic Inc.
o Koninklijke Philips N.V.
o Danaher
o Becton
o Dickinson and Company
o C.R. Bard, Inc.
o Devicor Medical Products Inc
· Breast Cancer Testing Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Breast Cancer Testing Market , By Country
o U.S. Breast Cancer Testing Market
o Canada Breast Cancer Testing Market
o Mexico Breast Cancer Testing Market
o Europe
§ Europe Breast Cancer Testing Market , By Country
o UK Breast Cancer Testing Market
o Germany Breast Cancer Testing Market
o France Breast Cancer Testing Market
o Russia Breast Cancer Testing Market
o Italy Breast Cancer Testing Market
o Rest of Europe Breast Cancer Testing Market
o Asia-Pacific
§ Asia-Pacific Breast Cancer Testing Market , By Country
o China Breast Cancer Testing Market
o Japan Breast Cancer Testing Market
o South Korea Breast Cancer Testing Market
o India Breast Cancer Testing Market
o Southeast Asia Breast Cancer Testing Market
o Rest of Asia-Pacific Breast Cancer Testing Market
o South America
§ South America Breast Cancer Testing Market
o Brazil Breast Cancer Testing Market
o Argentina Breast Cancer Testing Market
o Columbia Breast Cancer Testing Market
o Rest of South America Breast Cancer Testing Market
o Middle East and Africa
§ Middle East and Africa Breast Cancer Testing Market
o Saudi Arabia Breast Cancer Testing Market
o UAE Breast Cancer Testing Market
o Egypt Breast Cancer Testing Market
o Nigeria Breast Cancer Testing Market
o South Africa Breast Cancer Testing Market
o TurkeyBreast Cancer Testing Market
o Rest of MEA Breast Cancer Testing Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Breast Cancer Testing Market, By Type
5.1. Introduction
5.2. Global Breast Cancer Testing Revenue and Market Share by Type (2017-2021)
5.2.1. Global Breast Cancer Testing Revenue and Revenue Share by Type (2017-2021)
5.3. Imaging
5.3.1. Global Imaging Revenue and Growth Rate (2017-2021)
5.4. Biopsy
5.4.1. Global Biopsy Revenue and Growth Rate (2017-2021)
5.5. Genomic Tests
5.5.1. Global Genomic Tests Revenue and Growth Rate (2017-2021)
5.6. Blood Tests
5.6.1. Global Blood Tests Revenue and Growth Rate (2017-2021)
6. Breast Cancer Testing Market, By Region
6.1. Introduction
6.2. Global Breast Cancer Testing Revenue and Market Share by Regions
6.2.1. Global Breast Cancer Testing Revenue by Regions (2017-2021)
6.3. North America Breast Cancer Testing by Countries
6.3.1. North America Breast Cancer Testing Revenue and Growth Rate (2017-2021)
6.3.2. North America Breast Cancer Testing Revenue (Million USD) by Countries (2017-2021)
6.3.3. United States
6.3.3.1. United States Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.3.4. Canada
6.3.4.1. Canada Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.3.5. Mexico
6.3.5.1. Mexico Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.4. Europe Breast Cancer Testing by Countries
6.4.1. Europe Breast Cancer Testing Revenue and Growth Rate (2017-2021)
6.4.2. Europe Breast Cancer Testing Revenue (Million USD) by Countries (2017-2021)
6.4.3. Germany
6.4.3.1. Germany Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.4. France
6.4.4.1. France Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.5. UK
6.4.5.1. UK Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.6. Russia
6.4.6.1. Russia Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.7. Italy
6.4.7.1. Italy Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.5. Asia-Pacific Breast Cancer Testing by Countries
6.5.1. Asia-Pacific Breast Cancer Testing Revenue and Growth Rate (2017-2021)
6.5.2. Asia-Pacific Breast Cancer Testing Revenue (Million USD) by Countries (2017-2021)
6.5.3. China
6.5.3.1. China Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.4. Japan
6.5.4.1. Japan Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.5. Korea
6.5.5.1. Korea Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.6. India
6.5.6.1. India Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.6. South America Breast Cancer Testing by Countries
6.6.1. South America Breast Cancer Testing Revenue and Growth Rate (2017-2021)
6.6.2. South America Breast Cancer Testing Revenue (Million USD) by Countries (2017-2021)
6.6.3. Brazil
6.6.3.1. Brazil Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.4. Argentina
6.6.4.1. Argentina Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.5. Columbia
6.6.5.1. Columbia Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.7. Middle East and Africa Breast Cancer Testing by Countries
6.7.1. Middle East and Africa Breast Cancer Testing Revenue and Growth Rate (2017-2021)
6.7.2. Middle East and Africa Breast Cancer Testing Revenue (Million USD) by Countries (2017-2021)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.5. Egypt
6.7.5.1. Egypt Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.6. Nigeria
6.7.6.1. Nigeria Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.7. South Africa
6.7.7.1. South Africa Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.8. Turkey
6.7.8.1. Turkey Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7. Company Profiles
7.1. Genomic Health
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. Myriad Genetics, Inc.
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. NanoString Technologies, Inc.
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. Hologic Inc.
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
7.5. Koninklijke Philips N.V.
7.5.1. Business Overview
7.5.2. Service Portfolio
7.5.3. Strategic Developments
7.5.4. Financial Overview
7.6. Danaher
7.6.1. Business Overview
7.6.2. Service Portfolio
7.6.3. Strategic Developments
7.6.4. Financial Overview
7.7. Becton
7.7.1. Business Overview
7.7.2. Service Portfolio
7.7.3. Strategic Developments
7.7.4. Financial Overview
7.8. Dickinson and Company
7.8.1. Business Overview
7.8.2. Service Portfolio
7.8.3. Strategic Developments
7.8.4. Financial Overview
7.9. C.R. Bard, Inc.
7.9.1. Business Overview
7.9.2. Service Portfolio
7.9.3. Strategic Developments
7.9.4. Financial Overview
7.10. Devicor Medical Products Inc
7.10.1. Business Overview
7.10.2. Service Portfolio
7.10.3. Strategic Developments
7.10.4. Financial Overview
8. Breast Cancer Testing Market Forecast (2022-2027)
8.1. Global Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2022-2027)
8.2. Breast Cancer Testing Market Forecast by Regions (2022-2027)
8.2.1. North America Breast Cancer Testing Market Forecast (2022-2027)
8.2.1.1. United States Breast Cancer Testing Market Forecast (2022-2027)
8.2.1.2. Canada Breast Cancer Testing Market Forecast (2022-2027)
8.2.1.3. Mexico Breast Cancer Testing Market Forecast (2022-2027)
8.2.2. Europe Breast Cancer Testing Market Forecast (2022-2027)
8.2.2.1. Germany Breast Cancer Testing Market Forecast (2022-2027)
8.2.2.2. France Breast Cancer Testing Market Forecast (2022-2027)
8.2.2.3. UK Breast Cancer Testing Market Forecast (2022-2027)
8.2.2.4. Russia Breast Cancer Testing Market Forecast (2022-2027)
8.2.2.5. Italy Breast Cancer Testing Market Forecast (2022-2027)
8.2.2.6. Rest of Europe Breast Cancer Testing Market Forecast (2022-2027)
8.2.3. Asia-Pacific Breast Cancer Testing Market Forecast (2022-2027)
8.2.3.1. China Breast Cancer Testing Market Forecast (2022-2027)
8.2.3.2. Japan Breast Cancer Testing Market Forecast (2022-2027)
8.2.3.3. Korea Breast Cancer Testing Market Forecast (2022-2027)
8.2.3.4. India Breast Cancer Testing Market Forecast (2022-2027)
8.2.3.5. Southeast Asia Breast Cancer Testing Market Forecast (2022-2027)
8.2.3.6. Rest of Asia-Pacific Breast Cancer Testing Market Forecast (2022-2027)
8.2.4. South America Breast Cancer Testing Market Forecast (2022-2027)
8.2.4.1. Brazil Breast Cancer Testing Market Forecast (2022-2027)
8.2.4.2. Argentina Breast Cancer Testing Market Forecast (2022-2027)
8.2.4.3. Columbia Breast Cancer Testing Market Forecast (2022-2027)
8.2.4.4. Rest of South America Breast Cancer Testing Market Forecast (2022-2027)
8.2.5. Middle East and Africa Breast Cancer Testing Market Forecast (2022-2027)
8.2.5.1. Saudi Arabia Breast Cancer Testing Market Forecast (2022-2027)
8.2.5.2. United Arab Emirates Breast Cancer Testing Market Forecast (2022-2027)
8.2.5.3. Egypt Breast Cancer Testing Market Forecast (2022-2027)
8.2.5.4. Nigeria Breast Cancer Testing Market Forecast (2022-2027)
8.2.5.5. South Africa Breast Cancer Testing Market Forecast (2022-2027)
8.2.5.6. Turkey Breast Cancer Testing Market Forecast (2022-2027)
8.2.5.7. Rest of Middle East and Africa Breast Cancer Testing Market Forecast (2022-2027)
8.3. Breast Cancer Testing Market Forecast by Type (2022-2027)
8.3.1. Breast Cancer Testing Forecast by Type (2022-2027)
8.3.2. Breast Cancer Testing Market Share Forecast by Type (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Breast Cancer Testing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Breast Cancer Testing Revenue and Revenue Share by Type (2017-2019)
Figure Global Imaging Revenue and Growth Rate (2017-2019)
Figure Global Biopsy Revenue and Growth Rate (2017-2019)
Figure Global Genomic Tests Revenue and Growth Rate (2017-2019)
Figure Global Blood Tests Revenue and Growth Rate (2017-2019)
Table Global Breast Cancer Testing Revenue by Regions (2017-2019)
Figure North America Breast Cancer Testing Growth Rate (2017-2019)
Figure North America Breast Cancer Testing Revenue and Growth Rate (2017-2019)
Figure North America Breast Cancer Testing by Countries (2017-2019)
Figure North America Breast Cancer Testing Revenue (Million USD) by Countries (2017-2019)
Figure United States Breast Cancer Testing Growth Rate (2017-2019)
Figure United States Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Breast Cancer Testing Growth Rate (2017-2019)
Figure Canada Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Breast Cancer Testing Growth Rate (2017-2019)
Figure Mexico Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Breast Cancer Testing Growth Rate (2017-2019)
Figure Europe Breast Cancer Testing Revenue and Growth Rate (2017-2019)
Figure Europe Breast Cancer Testing by Countries (2017-2019)
Figure Europe Breast Cancer Testing Revenue (Million USD) by Countries (2017-2019)
Figure Germany Breast Cancer Testing Growth Rate (2017-2019)
Figure Germany Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Breast Cancer Testing Growth Rate (2017-2019)
Figure France Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Breast Cancer Testing Growth Rate (2017-2019)
Figure UK Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Breast Cancer Testing Growth Rate (2017-2019)
Figure Russia Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Breast Cancer Testing Growth Rate (2017-2019)
Figure Italy Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Breast Cancer Testing Growth Rate (2017-2019)
Figure Rest of Europe Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Breast Cancer Testing Growth Rate (2017-2019)
Figure Asia-Pacific Breast Cancer Testing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Breast Cancer Testing by Countries (2017-2019)
Figure Asia-Pacific Breast Cancer Testing Revenue (Million USD) by Countries (2017-2019)
Figure China Breast Cancer Testing Growth Rate (2017-2019)
Figure China Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Breast Cancer Testing Growth Rate (2017-2019)
Figure Japan Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Breast Cancer Testing Growth Rate (2017-2019)
Figure Korea Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Breast Cancer Testing Growth Rate (2017-2019)
Figure India Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Breast Cancer Testing Growth Rate (2017-2019)
Figure Southeast Asia Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Breast Cancer Testing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Breast Cancer Testing Growth Rate (2017-2019)
Figure South America Breast Cancer Testing Revenue and Growth Rate (2017-2019)
Figure South America Breast Cancer Testing by Countries (2017-2019)
Figure South America Breast Cancer Testing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Breast Cancer Testing Growth Rate (2017-2019)
Figure Brazil Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Breast Cancer Testing Growth Rate (2017-2019)
Figure Argentina Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Breast Cancer Testing Growth Rate (2017-2019)
Figure Columbia Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Breast Cancer Testing Growth Rate (2017-2019)
Figure Rest of South America Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Breast Cancer Testing Growth Rate (2017-2019)
Figure Middle East and Africa Breast Cancer Testing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Breast Cancer Testing by Countries (2017-2019)
Figure Middle East and Africa Breast Cancer Testing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Breast Cancer Testing Growth Rate (2017-2019)
Figure Saudi Arabia Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Breast Cancer Testing Growth Rate (2017-2019)
Figure United Arab Emirates Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Breast Cancer Testing Growth Rate (2017-2019)
Figure Egypt Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Breast Cancer Testing Growth Rate (2017-2019)
Figure Nigeria Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Breast Cancer Testing Growth Rate (2017-2019)
Figure South Africa Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Breast Cancer Testing Growth Rate (2017-2019)
Figure Turkey Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Breast Cancer Testing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Table Genomic Health Breast Cancer Testing Financial Overview
Table Myriad Genetics, Inc. Breast Cancer Testing Financial Overview
Table NanoString Technologies, Inc. Breast Cancer Testing Financial Overview
Table Hologic Inc. Breast Cancer Testing Financial Overview
Table Koninklijke Philips N.V. Breast Cancer Testing Financial Overview
Table Danaher Breast Cancer Testing Financial Overview
Table Becton Breast Cancer Testing Financial Overview
Table Dickinson and Company Breast Cancer Testing Financial Overview
Table C.R. Bard, Inc. Breast Cancer Testing Financial Overview
Table Devicor Medical Products Inc Breast Cancer Testing Financial Overview
Figure Global Breast Cancer Testing Revenue (Millions USD) and Growth Rate (2019-2027)
Table Breast Cancer Testing Market Forecast by Regions (2019-2027)
Figure North America Breast Cancer Testing Market Forecast (2019-2027)
Figure United States Breast Cancer Testing Market Forecast (2019-2027)
Figure Canada Breast Cancer Testing Market Forecast (2019-2027)
Figure Mexico Breast Cancer Testing Market Forecast (2019-2027)
Figure Europe Breast Cancer Testing Market Forecast (2019-2027)
Figure Germany Breast Cancer Testing Market Forecast (2019-2027)
Figure France Breast Cancer Testing Market Forecast (2019-2027)
Figure UK Breast Cancer Testing Market Forecast (2019-2027)
Figure Russia Breast Cancer Testing Market Forecast (2019-2027)
Figure Italy Breast Cancer Testing Market Forecast (2019-2027)
Figure Rest of Europe Breast Cancer Testing Market Forecast (2019-2027)
Figure Asia-Pacific Breast Cancer Testing Market Forecast (2019-2027)
Figure China Breast Cancer Testing Market Forecast (2019-2027)
Figure Japan Breast Cancer Testing Market Forecast (2019-2027)
Figure Korea Breast Cancer Testing Market Forecast (2019-2027)
Figure India Breast Cancer Testing Market Forecast (2019-2027)
Figure Southeast Asia Breast Cancer Testing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Breast Cancer Testing Market Forecast (2019-2027)
Figure South America Breast Cancer Testing Market Forecast (2019-2027)
Figure Brazil Breast Cancer Testing Market Forecast (2019-2027)
Figure Argentina Breast Cancer Testing Market Forecast (2019-2027)
Figure Columbia Breast Cancer Testing Market Forecast (2019-2027)
Figure Rest of South America Breast Cancer Testing Market Forecast (2019-2027)
Figure Middle East and Africa Breast Cancer Testing Market Forecast (2019-2027)
Figure Saudi Arabia Breast Cancer Testing Market Forecast (2019-2027)
Figure United Arab Emirates Breast Cancer Testing Market Forecast (2019-2027)
Figure Egypt Breast Cancer Testing Market Forecast (2019-2027)
Figure Nigeria Breast Cancer Testing Market Forecast (2019-2027)
Figure South Africa Breast Cancer Testing Market Forecast (2019-2027)
Figure Turkey Breast Cancer Testing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Breast Cancer Testing Market Forecast (2019-2027)
Figure Global Breast Cancer Testing Forecast by Type (2019-2027)
Figure Global Breast Cancer Testing Market Share Forecast by Type (2019-2027)
Figure Global Breast Cancer Testing Forecast by Type (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|